Indiana University GI Neuromuscular Pathology Prospective Registry
Principle Investigator: John M. Wo, MD
Duration: 2 years
Primary Outcomes Measured:
Follow up clinical data will be obtained before, 6 months, 1.5 years, and 2 years after the full thickness biopsy
Follow up data PAGI_SYM Overall Treatment Effect by Patient Overall Treatment Effect by Physician
Secondary Outcomes Measured:
Responders will be defined as >50% improvement of the GCSI total score at 6 month after surgical GES.
Patients with gastroparesis from type 1 DM versus patients with idiopathic gastroparesis.
Patients with gastroparesis from type 1 DM versus gastroparesis from type 2 DM.
Neuromuscular pathology results of the gastric body and proximal jejunum will be correlated with the following: Symptom severity (GCSI total score), predominant symptom presentation, severity of delayed gastric emptying.
Interested in this study? Please contact the coordinator below: Travis Putzke email@example.com (317) 278-2064